26 related articles for article (PubMed ID: 70642)
1. A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
Kalliolia E; Silajdžić E; Nambron R; Costelloe SJ; Martin NG; Hill NR; Frost C; Watt HC; Hindmarsh P; Björkqvist M; Warner TT
PLoS One; 2015; 10(10):e0138848. PubMed ID: 26431314
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients.
Wang R; Ross CA; Cai H; Cong WN; Daimon CM; Carlson OD; Egan JM; Siddiqui S; Maudsley S; Martin B
Front Physiol; 2014; 5():231. PubMed ID: 25002850
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine disturbances in Huntington's disease.
Saleh N; Moutereau S; Durr A; Krystkowiak P; Azulay JP; Tranchant C; Broussolle E; Morin F; Bachoud-Lévi AC; Maison P
PLoS One; 2009; 4(3):e4962. PubMed ID: 19319184
[TBL] [Abstract][Full Text] [Related]
4. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.
Li SH; Yu ZX; Li CL; Nguyen HP; Zhou YX; Deng C; Li XJ
J Neurosci; 2003 Jul; 23(17):6956-64. PubMed ID: 12890790
[TBL] [Abstract][Full Text] [Related]
5. Diminished prolactin reserve with myotonic dystrophy.
May PB; Renny A; Bastek J; Giglio W; Schneider G; Ertel N
J Endocrinol Invest; 1980; 3(4):415-8. PubMed ID: 6782154
[TBL] [Abstract][Full Text] [Related]
6. The endocrine profile of bromocriptine: its application in endocrine diseases.
Lancranjan I
J Neural Transm; 1981; 51(1-2):61-82. PubMed ID: 6455501
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN
J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607
[TBL] [Abstract][Full Text] [Related]
8. Dopamine: a prolactin-inhibiting hormone.
Ben-Jonathan N
Endocr Rev; 1985; 6(4):564-89. PubMed ID: 2866952
[No Abstract] [Full Text] [Related]
9. [Huntington chorea. Review of the most recent aspects of research].
Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
[TBL] [Abstract][Full Text] [Related]
10. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
Hayden MR; Vinik AI; Paul M; Beighton P
Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
[TBL] [Abstract][Full Text] [Related]
11. Prolactin control in Huntington's chorea.
Müller EE; Cocchi D; Mantegazza P; Parati EA; Caraceni T
Lancet; 1977 Oct; 2(8041):764-5. PubMed ID: 71573
[No Abstract] [Full Text] [Related]
12. Studies of hypothalamic function in Huntington's chorea.
Lavin PJ; Bone I; Sheridan P
J Neurol Neurosurg Psychiatry; 1981 May; 44(5):414-8. PubMed ID: 6455503
[TBL] [Abstract][Full Text] [Related]
13. Functional evaluation of prolactin secretion: a guide to therapy.
Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
Caine E; Kartzinel R; Ebert M; Carter AC
Life Sci; 1978 Mar; 22(10):911-8. PubMed ID: 147978
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
